LaBarre Michael J. 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Feb 21, 2025
Insider Transaction Report
Form 4
LaBarre Michael J.
VP, Product Development
Transactions
- Award
Option to Purchase Common Stock
2025-02-20+11,902→ 11,902 totalExercise: $57.44From: 2026-02-20Exp: 2035-02-20→ Common Stock (11,902 underlying) - Award
Restricted Stock Units
2025-02-20+11,230→ 11,230 totalExercise: $0.00From: 2026-02-20→ Common Stock (11,230 underlying)
Footnotes (2)
- [F1]This option vests one-fourth on such date and then 1/48th monthly thereafter.
- [F2]This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.